CVS Health

CVS

Market cap $100B

WOONSOCKET, R.I., Jan. 15, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Tuesday, February 10th, 2026, at 8:00 a.m.

Building on 18 months of proven success, the initiative will scale evidence-based solutions to improve pregnancy and postpartum outcomes for New Yorkers NEW YORK, Jan. 14, 2026 /PRNewswire/ -- The CVS Health Foundation granted the American Diabetes Association® (ADA) $2.6 million to expand its maternal health initiative to two additional communities within New York City. This expansion builds on the tremendous success of the program's first 18 months, which improved early gestational diabetes (GDM) screening and care coordination for hundreds of patients at Wyckoff Heights Medical Center in Brooklyn.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.

Gilead Sciences' new HIV prevention drug has been added to CVS Health's commercial insurance plans, the drugmaker's CEO Daniel O'Day said at a major industry conference that kicked off on Monday in San Francisco.

CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

In November, we (my wife and I) received a dividend income total of $1,489.90. Another $1,000+. Capital One Financial. After they acquired Discover, I was not sure what to expect.

WOONSOCKET, R.I., Jan. 9, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, February 11th, 2026, at 8:00 a.m.

Building on a strong 2025, CVS Health's outlook for 2026 and beyond looks promising. Amgen is developing newer drug products that will address a recent patent cliff.